No supplier or customer ties in TECX's filings yet. The map draws only what companies disclose to the SEC; ties named in other companies' filings join as the graph reads them.
Tectonic is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors. We have developed a proprietary technology platform called GEODe™ to enable the discovery and development of GPCR-targeted biologic medicines that can modify the course of disease, by addressing challenges that have limited the pace of innovation in this field. Our focus is on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life.
Nothing on the wire mentions TECX yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How TECX has moved on past release days vs its typical ±3.3% day, and how often it closed up. Computed from daily closes — not a forecast.